APA

Nauck M. A., Hompesch M., Filipczak R., Le T. D. T., Zdravkovic M. & Gumprecht J. (20061114). Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Chicago

Nauck M A, Hompesch M, Filipczak R, Le T D T, Zdravkovic M and Gumprecht J. 20061114. Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Harvard

Nauck M. A., Hompesch M., Filipczak R., Le T. D. T., Zdravkovic M. and Gumprecht J. (20061114). Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

MLA

Nauck M A, Hompesch M, Filipczak R, Le T D T, Zdravkovic M and Gumprecht J. Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 20061114.